Laurie Childs
Medical · West Jordan, UTNPI 1235355819
Payments from drug & device makers
Across 140 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$264
- Pharming Healthcare, Inc.$149
- Kaleo, Inc.$130
- CSL Behring$116
- Grifols USA, LLC$113
- plus $796 from 19 others
What the payments were for
- Food & beverage$2,666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 58 | $1,099 |
| GSK | 21 | $264 |
| Pharming Healthcare, Inc. | 3 | $149 |
| Kaleo, Inc. | 7 | $130 |
| CSL Behring | 5 | $116 |
| Grifols USA, LLC | 4 | $113 |
| Teva Pharmaceuticals USA, Inc. | 5 | $87 |
| Biocryst US Sales Co., LLC | 4 | $75 |
| Sanofi | 4 | $67 |
| Bio Products Laboratory USA, Inc. | 3 | $64 |
| Optinose US, Inc. | 3 | $58 |
| Pfizer | 3 | $52 |
| ADMA Biomanufacturing LLC | 2 | $52 |
| Novartis | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Boehringer Ingelheim | 2 | $40 |
| Octapharma USA, Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| AbbVie | 1 | $24 |
| Kedrion Biopharma, Inc. | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Ionis Pharmaceuticals, Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $18 |
| Amgen | 1 | $17 |
How this compares
$2,666 in reported general payments places this provider in the 70th percentile of 263 medical providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,161 |
| DuleraMometasone/Formoterol | 21 | $7,171 |
| Spiriva RespimatTiotropium Bromide | 11 | $7,050 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $7,003 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 37 | $4,336 |
| Azelastine Hcl | 20 | $577 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $375 |
| Fluticasone Propionate | 19 | $352 |
| Montelukast Sodium | 65 | $314 |
| Levocetirizine Dihydrochloride | 13 | $131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere | $1,099 | $8,16113 claims |
| Boehringer IngelheimSpiriva Respimat | $40 | $7,05011 claims |
| GSKBreo Ellipta | $264 | $7,00314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 263 medical providers in Utah.
Other medical in West Jordan
- Jared MathisWest Jordan$4K
- Kelly CurranWest Jordan$4K
- Collin McDonaldWest Jordan$3K
- Christy LovelessWest Jordan$3K
- Kyle HarmerWest Jordan$3K
- Elisa WilcoxSalt Lake City$178K
- Viet leSalt Lake City$65K
- Val WarnerLayton$51K
- Carmelo DiazSalt Lake City$35K
- Shari CombeSalt Lake City$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.